Position in ADMA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$3,464,635
-$26,167,065 QoQ
Shares Held
413,935
-87.4% QoQ
Ownership
0.185%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#62
of 323 holders
Holding Since
Mar 2020
12 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Derivatives in ADMA
reported options exposure · as of Jun 30, 2026CallValue
$419,337
CallShares
50,100
PutValue
$293,787
PutShares
35,100
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Point72 Asset Management, L.P. holds $2,243,273,342 across 172 Biotechnology names. ADMA ranks #87 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
4,473,478 | $158,316,386 | |
| 2 | CYTK |
Cytokinetics Inc
|
1,587,712 | $135,257,185 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
1,525,782 | $113,640,243 | |
| 4 | AXSM |
Axsome Therapeutics, Inc.
|
416,516 | $101,950,621 | |
| 5 | LEGN |
Legend Biotech Corp
|
3,076,124 | $88,838,461 | |
| 6 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
137,029 | $73,577,721 | |
| 7 | CELC |
Celcuity Inc.
|
650,916 | $68,098,831 | |
| 8 | ACAD |
Acadia Pharmaceuticals Inc
|
2,433,168 | $61,559,150 |
All Filings in ADMA
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $419,337 | 50,100 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $293,787 | 35,100 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $3,464,635 | 413,935 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $188,309 | 20,900 | Call | Defined | 2026-05-15 | |
| 2026-03-31 | $29,631,700 | 3,288,757 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $860,928 | 47,200 | Call | Defined | 2026-02-17 | |
| 2025-12-31 | $7,184,352 | 393,879 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $19,380,754 | 1,322,016 | Shares | Defined | 2025-11-14 | |
| 2025-03-31 | $16,815,550 | 847,558 | Shares | Defined | 2025-07-21 | |
| 2025-03-31 | $5,952,000 | 300,000 | Call | Defined | 2025-07-21 | |
| 2024-12-31 | $3,641,390 | 212,326 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,219,109 | 111,011 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,156,626 | 103,455 | Shares | Defined | 2024-09-16 | |
| 2023-12-31 | $1,105,198 | 244,513 | Shares | Defined | 2024-02-14 | |
| 2023-03-31 | $6,403,446 | 1,934,576 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,725,468 | 1,991,100 | Shares | Defined | 2023-05-15 | |
| 2020-03-31 | $720,000 | 250,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||